Combined Use of Carboxyl-Directed Protein Pegylation and Vector-Mediated Blood-Brain Barrier Drug Delivery System Optimizes Brain Uptake of Brain-Derived Neurotrophic Factor Following Intravenous Administration

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Pharmaceutical Research

• Publication date

  1998-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1011981927620PMID 9587954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.

  1997cited by this paper
• Pharmacology of neurotrophic factors.

  1997cited by this paper
• Carboxyl-directed Pegylation of Brain-derived Neurotrophic Factor Markedly Reduces Systemic Clearance with Minimal Loss of Biologic Activity

  1997cited by this paper
• Drug Delivery to the Brain

  1997cited by this paper
• Brain drug delivery of small molecules using immunoliposomes.

  1996cited by this paper
• Classical electrostatics in biology and chemistry.

  1995cited by this paper
• Vector-mediated peptide drug delivery to the brain.

  1995cited by this paper
• Transport of [125I]transferrin through the rat blood-brain barrier.

  1995cited by this paper
• In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium.

  1994cited by this paper
• Formation of heterodimers from three neurotrophins, nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor.

  1994cited by this paper
• Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery

  1994cited by this paper
• Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor.

  1993cited by this paper
• Delivery of peptides and proteins through the blood-brain barrier.

  1993cited by this paper
• Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product.

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo.

  1991cited by this paper
• Trkl3 mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor

  1991cited by this paper
• Human blood-brain barrier transferrin receptor.

  1987cited by this paper
• Receptor binding activities of biotinylated derivatives of beta-nerve growth factor.

  1986cited by this paper
• Receptor Binding Activities of Biotinylated Derivatives of β‐Nerve Growth Factor

  1986cited by this paper
• Transferrin receptor on endothelium of brain capillaries

  1984cited by this paper
• Avidin.

  1975cited by this paper

• Disruption of BDNF signalling in neuropathologies.

  2026cites this paper
• Therapeutic effects of CGS21680, a selective A2A receptor agonist, via BDNF-related pathways in R106W mutation Rett syndrome model.

  2025cites this paper
• The intriguing role of platelets as custodians of brain-derived neurotrophic factor

  2024cites this paper
• Exercise training and BDNF injections alter APP processing enzymes and improve cognition.

  2023cites this paper
• Applications of Nanoparticles in Alzheimer’s Disease

  2023cites this paper
• Promising new pharmacological targets for depression: the search for efficacy.

  2023cites this paper
• Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

  2022cites this paper
• Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics

  2022cites this paper
• Enhancing autophagy in Alzheimer's disease through drug repositioning.

  2022cites this paper
• Advances in Antibody-Based Therapeutics for Cerebral Ischemia

  2022cites this paper
• Review of Current Strategies for Delivering Alzheimer's Disease Drugs Across the Blood-Brain Barrier.

  2022cites this paper
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• APP Processing: A Biochemical Competition Influenced by Exercise-Induced Signaling Mediators?

  2022cites this paper
• Targeting the blood-brain barrier for the delivery of stroke therapies.

  2021cites this paper
• Drug delivery platforms for neonatal brain injury.

  2021cites this paper
• Changes in white matter microstructure and MRI-derived cerebral blood flow after 1-week of exercise training

  2021cites this paper
• Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies.

  2020cites this paper
• Gait deficits and loss of striatal tyrosine hydroxlase/trk-b are restored following 7,8-dihydroxyflavone treatment in a progressive mptp mouse model of parkinson's disease.

  2020cites this paper
• Safe Administration of Carbon Nanotubes by Intravenous Pathway in BALB/c Mice

  2020cites this paper
• Challenges of BDNF-based therapies: from common to rare diseases.

  2020cites this paper
• Upregulation of BDNF and hippocampal functions by a hippocampal ligand of PPARα.

  2020cites this paper
• Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.

  2019cites this paper
• Effects of the TrkB Receptor Agonist 7,8-Dihydroxyflavone on the Serotonin System and the Genes Encoding BDNF, TrkB, and Bax in the Mouse Brain

  2019cites this paper
• Effects of Exercise on Cognitive Performance in Children and Adolescents with ADHD: Potential Mechanisms and Evidence-based Recommendations

  2019cites this paper
• Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain

  2019cites this paper
• Metastatic brain tumor models and drug brain penetration analysis

  2019cites this paper
• Local Delivery of Brain-Derived Neurotrophic Factor Enables Behavioral Recovery and Tissue Repair in Stroke-Injured Rats

  2019cites this paper
• Targeting the transferrin receptor for brain drug delivery.

  2019cites this paper
• University of Southern Denmark Effects of Exercise on Cognitive Performance in Children and Adolescents with ADHD

  2019cites this paper
• Effects of the TrkB Receptor Agonist 7,8-Dihydroxyflavone on the Serotonin System and the Genes Encoding BDNF, TrkB, and Bax in the Mouse Brain

  2019cites this paper
• Transcytosis at the blood-brain barrier.

  2019cites this paper
• Association of neuronal repair biomarkers with delirium among survivors of critical illness.

  2019cites this paper
• Influencing neuroplasticity in stroke treatment with advanced biomaterials-based approaches.

  2019influential citation
• Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier

  2019cites this paper
• STAT6, PBX2, and PBRM1 Emerge as Predicted Regulators of 452 Differentially Expressed Genes Associated With Puberty in Brahman Heifers

  2018cites this paper
• The Causative and Curative Roles of Brain-Derived Neurotrophic Factor in Parkinson’s Disease

  2018cites this paper
• Synergy and convergence of pathways controlling functional regeneration in the spinal cord

  2018cites this paper
• Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer's dementia.

  2018cites this paper
• Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

  2018cites this paper
• Whole Body Vibration Therapy after Ischemia Reduces Brain Damage in Reproductively Senescent Female Rats

  2018cites this paper
• Epigenetics in mental and neurodegenerative disorders

  2018cites this paper
• Preparation and Characterization of Biocompatible Chitosan Nanoparticles for Targeted Brain Delivery of Peptides.

  2018cites this paper
• Encapsulation-Free Local Delivery of BDNF Enhances Recovery in Stroke-Injured Rats

  2018cites this paper
• Exercise and circulating BDNF: Mechanisms of release and implications for the design of exercise interventions.

  2018cites this paper
• Fine-tuning the physicochemical properties of peptide-based blood-brain barrier shuttles.

  2018cites this paper
• Development of a PEGylated-Based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood-Brain Barrier.

  2018cites this paper
• A Brain-Derived Neurotrophic Factor Mimetic Is Sufficient to Restore Cone Photoreceptor Visual Function in an Inherited Blindness Model

  2017cites this paper
• Targeting Malignant Brain Tumors with Antibodies

  2017influential citation
• Therapeutic strategies in neurodegenerative diseases

  2017cites this paper
• Effects of progesterone administered after MPTP on dopaminergic neurons of male mice

  2017cites this paper
• Clinical Implications of Molecular PEGylation on Therapeutic Proteins

  2017cites this paper
• Block ionomer complex formulations for in vivo protein delivery

  2016cites this paper
• The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia

  2016cites this paper
• The Effects of Acute Exercise on Memory and Brain-Derived Neurotrophic Factor (BDNF).

  2016cites this paper
• Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?

  2016cites this paper
• Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis

  2016cites this paper
• Chapter 22 Molecular and Cellular Neuromodulation for Central Nervous System Injury and Regeneration

  2016cites this paper
• Delivery of Peptides and Proteins to the Brain Using Nano-Drug Delivery Systems and Other Formulations

  2016cites this paper
• Engineered BDNF producing cells as a potential treatment for neurologic disease

  2016cites this paper
• Engineered BDNF producing cells as a potential treatment for Huntington ' s disease and other neurological indications

  2016cites this paper
• Growth factor conjugation: strategies and applications.

  2015cites this paper
• Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease.

  2015influential citation
• 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders.

  2015cites this paper
• Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor

  2015cites this paper
• Brain-derived neurotrophic factor (BDNF) as a potential mechanism of the effects of acute exercise on cognitive performance

  2015cites this paper
• Signaling Pathways Involved in Cognitive Enhancement

  2015cites this paper
• Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier

  2014cites this paper
• Neurotrophic Factors, Clinical Features and Gender Differences in Depression

  2014cites this paper
• Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.

  2014cites this paper
• Current approaches to enhance CNS delivery of drugs across the brain barriers

  2014cites this paper
• Agile delivery of protein therapeutics to CNS.

  2014cites this paper
• From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)

  2013influential citation
• Antidepressant-Like Effects of Erythropoietin: A Focus on Behavioural and Hippocampal Processes

  2013cites this paper
• Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study

  2013cites this paper
• Valproic acid protection against the brachial plexus root avulsion‐induced death of motoneurons in rats

  2013cites this paper
• Transferrin Fusion Protein Therapies: Acetylcholine Receptor‐Transferrin Fusion Protein as a Model

  2013cites this paper
• Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides.

  2012cites this paper
• Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.

  2012cites this paper
• Long-Term Course of Brain-Derived Neurotrophic Factor Serum Levels in a Patient Treated with Deep Brain Stimulation of the Lateral Habenula

  2012cites this paper
• Neurological disorders and therapeutics targeted to surmount the blood–brain barrier

  2012cites this paper
• Current advances in using neurotrophic factors to treat neurodegenerative disorders

  2012cites this paper
• UC San Diego UC San Diego Previously Published Works Title Current advances in using neurotrophic factors to treat neurodegenerative disorders

  2012cites this paper
• Oriented collagen as a potential cochlear implant electrode surface coating to achieve directed neurite outgrowth

  2012cites this paper
• Schleuservermittelter Transport von Wirkstoffen ins Gehirn

  2011cites this paper
• Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres for Supporting Survival of Neural Stem Cells

  2011cites this paper
• Brain-Derived Neurotrophic Factor and Major Depression

  2011cites this paper
• Shuttle-mediated drug delivery to the brain.

  2011cites this paper
• Neuroprotection in experimental stroke with targeted neurotrophins

  2011cites this paper
• Potential therapeutic uses of BDNF in neurological and psychiatric disorders

  2011cites this paper
• Peripheral BDNF Produces Antidepressant-Like Effects in Cellular and Behavioral Models

  2010cites this paper
• Receptor-Mediated Transport of Drugs Across the BBB

  2010cites this paper
• Nanoparticulate devices for brain drug delivery

  2010cites this paper
• Influência dos receptores A2a da adenosina no efeito neuroprotector do BDNF na morte neuronal induzida

  2009cites this paper
• PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution.

  2009cites this paper
• Growth factors in ischemic stroke

  2009cites this paper
• Blood-Brain Barrier Transport for RNAi

  2009cites this paper
• CNS drug delivery systems: novel approaches.

  2009cites this paper
• Erythropoiesis-stimulating protein delivery in providing erythropoiesis and neuroprotection

  2008cites this paper
• Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice.

  2008cites this paper
• Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses.

  2008cites this paper